IP Library Granted Patent US 6,875,573
Granted Patent B2
US 6,875,573 · App. 10/190,967 · Granted Apr 5, 2005

DNA polymerases having amino acid substitutions and homologs thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,875,573
App. No.
10/190,967
Granted
Apr 5, 2005
Kind
B2
Abstract

Thermostable DNA polymerases both in native form and having single amino acid substitutions and optionally N-terminal deletions are disclosed. These polymerases exhibit a substantial improvement of DNA sequencing performance compared to Taq DNA polymerase. The instant DNA polymerases also possess improved salt tolerance.

Claims (5)

1. A purified recombinant thermostable DNA polymerase comprising the amino acid sequence set forth in FIG. 2 .

2. A method for synthesizing a fluorescently labeled polynucleotide, comprising the step of mixing the DNA polymerase of claim 1 with a primed template.

3. The method of claim 2 , wherein the primed template is a primed template in a chain termination sequencing reaction.

4. The method according to claim 2 , wherein the primed template is a primed template in a polymerase chain reaction.

5. A kit for synthesizing fluorescently labeled polynucleotides comprising the polymerase of claim 1 and a fluorescently labeled nucleotide.

Assignments (2)
CHANGE OF NAME Recorded Feb 14, 2006
From: AMERSHAM BIOSCIENCES CORP
To: GE HEALTHCARE BIO-SCIENCES CORP.
Reel/Frame 017164/0374 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2006
From: FULLER, CARL
To: AMERSHAM BIOSCIENCES CORP
Reel/Frame 017136/0862 →